---
document_datetime: 2023-09-21 20:15:29
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/exparel-liposomal-epar-all-authorised-presentations_en.pdf
document_name: exparel-liposomal-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.9633264
conversion_datetime: 2025-12-22 11:22:30.640257
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength     | Pharmaceutical Form                        | Route of Administration      | Immediate Packaging   | Content (concentration)   | Pack size   |
|------------------|-------------------|--------------|--------------------------------------------|------------------------------|-----------------------|---------------------------|-------------|
| EU/1/20/1489/001 | EXPAREL liposomal | 133 mg/10 ml | Prolonged-release dispersion for injection | Infiltration, Perineural use | vial (glass)          | 10 ml                     | 4 vials     |
| EU/1/20/1489/002 | EXPAREL liposomal | 133 mg/10 ml | Prolonged-release dispersion for injection | Infiltration, Perineural use | vial (glass)          | 10 ml                     | 10 vials    |
| EU/1/20/1489/003 | EXPAREL liposomal | 266 mg/20 ml | Prolonged-release dispersion for injection | Infiltration, Perineural use | vial (glass)          | 20 ml                     | 4 vials     |
| EU/1/20/1489/004 | EXPAREL liposomal | 266 mg/20 ml | Prolonged-release dispersion for injection | Infiltration, Perineural use | vial (glass)          | 20 ml                     | 10 vials    |